Company

Gilead Sciences Inc GILD

Tracked across 9 disclosed holders on Protégé.

5 tracked investors, latest 13F quarter ending 30 Jun 2026 · 3 members of Congress · 1 executive · latest filing 2 Oct 2026

Held by these investors

All of 5 tracked investors by weight in their own portfolio. Source: each investor's latest SEC Form 13F-HR; quarter end and filing date per row.
InvestorWeight in portfolioValue (13F)Quarter endingFiled
Holocene Advisors0.9%$406.4M2026-06-302026-08-14
Squarepoint Capital0.5%$230.3M2026-06-302026-08-14
Renaissance Technologies0.4%$280.1M2026-06-302026-08-13
Ken Griffin0.3%$439.7M2026-06-302026-08-14
Brevan Howard Asset Management0.2%$15.6M2026-06-302026-08-14

Members of Congress who disclosed trades

Disclosed trades by members of Congress. Net is buys minus sells at range midpoints. Source: STOCK Act periodic transaction reports; latest trade date per row.
PoliticianDisclosed activityEst. netLatest trade
Jared Moskowitz2 buys / 0 sells$16K2026-05-06
Josh Gottheimer1 buy / 0 sells$8K2026-01-27
Marjorie Greene1 buy / 0 sells$8K2024-12-24

Company executives who disclosed trades

Executives' own trades in this company's stock. Source: SEC Form 4; latest trade date per row.
ExecutiveDisclosed activityNetLatest trade
Daniel O'Day0 buys / 19 sells-$58.0M2026-10-01

Sources: SEC EDGAR (Form 13F-HR and Form 4) and the official House and Senate STOCK Act disclosures. Filings are quarterly or delayed, so current holdings may differ. Weights are each holder's own portfolio share, not a share of the company.

Open the companies explorer for GILD